Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 7
1948 5
1949 2
1950 7
1951 5
1952 6
1953 6
1954 1
1955 1
1956 5
1957 3
1958 2
1959 4
1960 3
1961 5
1962 2
1963 10
1964 16
1965 6
1966 8
1967 29
1968 46
1969 67
1970 74
1971 99
1972 165
1973 163
1974 253
1975 317
1976 380
1977 452
1978 581
1979 605
1980 600
1981 650
1982 728
1983 891
1984 1003
1985 1037
1986 1157
1987 1132
1988 1164
1989 1341
1990 1434
1991 1387
1992 1384
1993 1385
1994 1397
1995 1262
1996 1362
1997 1348
1998 1342
1999 1394
2000 1458
2001 1553
2002 1553
2003 1561
2004 1639
2005 1727
2006 1891
2007 1866
2008 1861
2009 1921
2010 2303
2011 2453
2012 2573
2013 2645
2014 2809
2015 2923
2016 2932
2017 2948
2018 3071
2019 3040
2020 1550
2021 79
Text availability
Article attribute
Article type
Publication date

Search Results

67,833 results
Results by year
Filters applied: . Clear all
Page 1
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
Mayer LD, Tardi P, Louie AC. Mayer LD, et al. Int J Nanomedicine. 2019 May 23;14:3819-3830. doi: 10.2147/IJN.S139450. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31213803 Free PMC article. Review.
In contrast, CPX-351 (Vyxeos) is a dual-drug liposomal encapsulation of cytarabine and daunorubicin that was rationally designed to improve efficacy over the traditional 7+3 cytarabine/daunorubicin chemotherapy regimen for patients with acute myeloid leukemia (AML). …
In contrast, CPX-351 (Vyxeos) is a dual-drug liposomal encapsulation of cytarabine and daunorubicin that was rationally designed to i …
Production of daunorubicin.
Stroshane RM. Stroshane RM. Adv Biotechnol Processes. 1984;3:141-61. Adv Biotechnol Processes. 1984. PMID: 6399841 Review. No abstract available.
A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.
Alves AC, Ribeiro D, Horta M, Lima JLFC, Nunes C, Reis S. Alves AC, et al. J R Soc Interface. 2017 Aug;14(133):20170408. doi: 10.1098/rsif.2017.0408. J R Soc Interface. 2017. PMID: 28855387 Free PMC article.
Daunorubicin is extensively used in chemotherapy for diverse types of cancer. Over the years, evidence has suggested that the mechanisms by which daunorubicin causes cytotoxic effects are also associated with interactions at the membrane level. ...
Daunorubicin is extensively used in chemotherapy for diverse types of cancer. Over the years, evidence has suggested that the mechani
Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
Aubel-Sadron G, Londos-Gagliardi D. Aubel-Sadron G, et al. Biochimie. 1984 May;66(5):333-52. doi: 10.1016/0300-9084(84)90018-x. Biochimie. 1984. PMID: 6380596 Review.
Daunorubicin and doxorubicin, two antibiotics belonging to the anthracycline group, are widely used in human cancer chemotherapy. ...In both cases, there is probably an action at the membrane level. It has to be noted that daunorubicin and doxorubicin have a particu
Daunorubicin and doxorubicin, two antibiotics belonging to the anthracycline group, are widely used in human cancer chemotherapy. ...
The discovery of daunorubicin.
Di Marco A, Cassinelli G, Arcamone F. Di Marco A, et al. Cancer Treat Rep. 1981;65 Suppl 4:3-8. Cancer Treat Rep. 1981. PMID: 7049379
The authors summarize the early studies on the isolation, structure determination, biological effects, and mechanism of action of daunorubicin (DNR). In fact, the relationship between affinity for DNA and biological activity was first recorded for DNR and later confirmed o …
The authors summarize the early studies on the isolation, structure determination, biological effects, and mechanism of action of daunoru
The influence of charge and lipophilicity of daunorubicin and idarubicin on their penetration of model biological membranes - Langmuir monolayer and electrochemical studies.
Matyszewska D. Matyszewska D. Biochim Biophys Acta Biomembr. 2020 Feb 1;1862(2):183104. doi: 10.1016/j.bbamem.2019.183104. Epub 2019 Oct 28. Biochim Biophys Acta Biomembr. 2020. PMID: 31672546 Free article.
The interactions of two selected anthracyclines, daunorubicin (DNR) and idarubicin (IDA), with phospholipid monolayers used as simple models of cell membranes, were investigated. ...Additionally, idarubicin was able to penetrate the precompressed DMPS monolayers more effec …
The interactions of two selected anthracyclines, daunorubicin (DNR) and idarubicin (IDA), with phospholipid monolayers used as simple …
Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
Cusack BJ, Young SP, Olson RD. Cusack BJ, et al. Cancer Chemother Pharmacol. 1995;35(3):213-8. doi: 10.1007/BF00686550. Cancer Chemother Pharmacol. 1995. PMID: 7805179
Fisher 344 rats received 5 mg kg-1 daunorubicin i.v. by bolus injection. Rats were killed at selected intervals for up to 1 week after daunorubicin administration for determination of concentrations of daunorubicin and daunorubicinol in the plasma, heart, liv …
Fisher 344 rats received 5 mg kg-1 daunorubicin i.v. by bolus injection. Rats were killed at selected intervals for up to 1 week afte …
Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
Ghirmai S, Mume E, Tolmachev V, Sjöberg S. Ghirmai S, et al. Carbohydr Res. 2005 Jan 17;340(1):15-24. doi: 10.1016/j.carres.2004.10.014. Carbohydr Res. 2005. PMID: 15620662
Daunorubicin and doxorubicin are efficient agents for cancer treatment. ...Furthermore, the antitumor effect could be enhanced by attaching the Auger electron emitter, (125)I, to daunorubicin and doxorubicin derivatives. In this context a number of ester, amide, and
Daunorubicin and doxorubicin are efficient agents for cancer treatment. ...Furthermore, the antitumor effect could be enhanced by att
Daunorubicin (Cerubidine).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1980 Apr 18;22(8):34-5. Med Lett Drugs Ther. 1980. PMID: 6988689 Clinical Trial. No abstract available.
Stability of [(N-piperidine)methylene]daunorubicin hydrochloride and [(N-pyrrolidine)methylene]daunorubicin hydrochloride in solid state.
Medenecka B, Zalewski P, Kycler W, Piekarski M, Lemiech W, Oszczapowicz I, Jelińska A. Medenecka B, et al. Acta Pol Pharm. 2014 May-Jun;71(3):431-8. Acta Pol Pharm. 2014. PMID: 25265823 Free article.
The influence of temperature and relative air humidity on the stability of two novel derivatives of daunorubicin: [(N-piperidine)methylene]daunorubicin hydrochloride and [(N-pyrrolidine)methylene]daunorubicin hydrochloride was investigated. ...
The influence of temperature and relative air humidity on the stability of two novel derivatives of daunorubicin: [(N-piperidine)meth …
67,833 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page